Apellis Pharmaceuticals, Inc. APLS
CIK 0001492422
Form 4 transactions dated Sep 1, 2023 to Sep 23, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $80.78M
Sep 1, 2023 – May 14, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-02-11 | DeLong Mark Jeffrey Chief Business & Strat Officer | Sale | $8.15K 368 shares sold | 0.32% sold Direct holding | ▾ |
| 2026-01-22 | Baumal Caroline Chief Medical Officer | Sale | $60.88K 2,797 shares sold | 3.13% sold Direct holding | ▾ |
| 2026-01-22 | Chopas James George VP/Chief Accounting Officer | Sale | $44.92K 2,064 shares sold | 3.98% sold Direct holding | ▾ |
| 2026-01-22 | DeLong Mark Jeffrey Chief Business & Strat Officer | Sale | $73.37K 3,371 shares sold | 4.12% sold Direct holding | ▾ |
| 2026-01-22 | Deschatelets Pascal Chief Scientific Officer | Sale | $129.03K 5,928 shares sold | 0.51% sold Direct holding | ▾ |
| 2026-01-22 | Francois Cedric Chief Executive Officer · Director | Sale | $591.84K 27,192 shares sold | 8.68% sold Direct holding | ▾ |
| 2026-01-22 | Nicholson Nur Chief Technical Officer | Sale | $168.14K 7,725 shares sold | 9.80% sold Direct holding | ▾ |
| 2026-01-22 | Sullivan Timothy Eugene Chief Financial Officer | Sale | $223.90K 10,287 shares sold | 9.87% sold Direct holding | ▾ |
| 2026-01-22 | Watson David O. General Counsel | Sale | $170.47K 7,832 shares sold | 8.13% sold Direct holding | ▾ |
| 2026-01-20 | Baumal Caroline Chief Medical Officer | Sale | $37.25K 1,882 shares sold | 2.06% sold Direct holding | ▾ |
Showing 25 / 25 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 25 of 25 purchase / sale groups and 30 of 198 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"APLS","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.